Companies/US/VCEL

VERICEL CORPORATION

Last · NASDAQ$40.25-0.05 (-0.12%)close · yahoo · 17h ago
Vol 384.5K ≈ 15.48M
Market cap$2.06B51.2M sh
P/E · TTM85.6fwd 47.6 · eps 0.47
Beta1.02vs S&P 500
Div yield0.00%annual · TTM
52w range
$28.95$49.32
Volume384.5Ksession

Issuer

Legal nameVERICEL CORPORATION
HQUnited States (US)
ListingUS VCEL
ISINUS92346J1088
SectorHealthcare
IndustryDrugs (Biotechnology)
SIC2836
CurrencyUSD
Entity registrysec:0000887359
CIK0000887359
LinkedIn
Employees398
AddressVericel Corp. 64 Sidney Street 02139-4170, Cambridge +617 588 5555
Headline financial metrics
Revenue$306.3M
Operating income$-7.6M
Net income$-4.1M
Free cash flow$29.4M
Operating margin-2.5%
Net margin-1.3%
Return on equity-1.1%
PeriodTTM 2026-06-30
Loading chart…

OpenFilings analyst

Our analyst

10-K · 2026-02-26

From latest 10-K · 2026-02-26

  • Accumulated Deficit High

Red flags

  • Accumulated Deficit High — Accumulated deficit / equity 106%

Upcoming earnings

1 event
1:30 PM UTC+1
Period
Sep 2026
Est. EPS
$0.06
Est. revenue
78.0M

Press & signals

1 recent
  • GlobeNewswire

    Vericel Reports Second Quarter 2026 Financial Results, Raises Full-Year Financial Guidance and Announces Share Repurchase Program

Documents

FormReporting forFiledFlags
2026-08-122026-08-140
2026-08-032026-08-050
2026-07-302026-07-310
2026-06-302026-07-30 1